211) clear if individuals who are at increased risk for future OA (i.e., individuals with |
212) Kidney transplant recipients at high risk for infections might benefit from enh |
213) lia-specific gene in the brain, increases risk for late-onset Alzheimer’s disease |
214) mmon health outcomes, e.g., for increased risk for later-life maternal metabolic eff |
215) grants and refugees (AIR) are at elevated risk for low or no participation in PA due |
216) netic variation contributes to individual risk for many complex diseases and is incr |
217) upting chemicals (EDCs) with an increased risk for metabolic syndrome, obesity, and |
218) investigation of their potential roles in risk for methamphetamine addiction and the |
219) ation does not independently increase the risk for mortality in very low birth weigh |
220) ation does not independently increase the risk for mortality. |
221) molecules which can be applied to assess risk for osteoporotic fractures. |
222) AFLD stages, but its invasiveness poses a risk for patients, which is why new, non-i |
223) cific granule abundance at birth predicts risk for pediatric asthma and pulmonary fu |
224) nal age, reproducibly associated with the risk for pediatric asthma. |
225) were small, retrospective studies at high risk for potential bias. |
226) e-control studies, there was an increased risk for prematurity and small for gestati |
227) • There was an increased risk for prematurity, and no increased ris |
228) e need for more information on geographic risk for public health planning. |
229) rphic variant that may be associated with risk for schizophrenia and bipolar disorde |
230) Peers of individuals at risk for suicide may be able to play impor |
231) Organ at risk for the immune system should be consi |
232) us (HBV) infection is a major etiological risk for the incidence of hepatocellular c |
233) ple opportunities for youth and adults at risk for tobacco initiation to be exposed |
234) show untapped potential in improving the risk-grading for peri-implantitis. |
235) ons and close proximity of many organs-at-risk. |
236) anastomoses, a potentially safe level of risk). |
237) tial AP and PP effects on cardiometabolic risk. |
238) embolism (VTE) but also increase bleeding risk. |
239) have been shown to lower cardiometabolic risk. |
240) nisms shared in regulating CRP/IL6 and BC risk. |
241) s were as detrimental concerning suicidal risk. |
242) an isolated event portending less future risk. |
243) rk and/or the steps taken to address this risk. |
|